On March 15, 2023, the website of the Center for Drug Review and Evaluation (CDE) of the State Medic

Pfizer announced that the U.S. Food and Drug Administration (FDA) has granted priority review status

Scientists from the University of Illinois at Urbana-Champaign and other institutes found that PAC-1

2022.12.12, the US FDA announced the approval of Mirati Therapeutics' oral KRAS G12C inhibitor a

Abbvie announced that the European Commission has approved a new indication for Skyrizi, its novel a

AstraZeneca (AstraZeneca) recently reported positive, high-level results from its phase II trial of

Beijing, Oct. 9, 2022 -- Bayer announced that the global initiative for state and drug administratio

On September 13, 2022, Shanghai Haihe Pharmaceutical Research and Development Co., Ltd. and South Ko

Parkinson's disease is notoriously difficult to diagnose because it relies primarily on the onse

Targeting a parasite's DNA could be a more effective way to combat malaria, new research from th